LBA47Randomized, open-label, perioperative phase II study evaluating nivolumab alone versus nivolumab plus ipilimumab in patients with resectable HCC
Kaseb, A, Duda, D G, Tran Cao, H S, Abugabal, Y I, Vence, L M, Rashid, A, Carmagnani Pestana, R, Blando, J M, Singh, S, Vauthey, J N, Chun, Y S, Tzeng, C-W D, Sakamuri, D, Wolff, R A, Yao, J C, Allison, J, Sharma, P
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article